Kathryn J. McCullough, MA

St. Jude researchers examine factors that affect access to care for patients with sickle cell disease.

Over a decade of research brings a treatment to the forefront for children with low-grade gliomas. For Olivia Thatcher, that treatment came at the right time.

Research in integrated, molecular diagnostics gave Fletcher Fazenbaker’s family something they thought they’d never get — a diagnosis and treatment plan.

Learn how work at St. Jude is illuminating the interplay between blood stem cells and the bone marrow microenvironment to further understand hematologic malignancies.

At St. Jude, clinical trial SJiMB21 seeks to provide treatment strategies for infants and young children diagnosed with medulloblastoma that place the patient, not just the tumor, at the center of care.